ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 169 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $605,475 | -26.0% | 32,500 | +3.2% | 0.00% | -100.0% |
| Q2 2023 | $818,370 | -9.5% | 31,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $904,680 | -13.2% | 31,500 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,041,920 | +28.0% | 35,200 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $814,000 | +6.7% | 34,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $763,000 | -11.2% | 34,200 | 0.0% | 0.00% | – |
| Q1 2022 | $859,000 | -24.6% | 34,200 | +7.5% | 0.00% | -100.0% |
| Q4 2021 | $1,139,000 | -15.8% | 31,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,353,000 | -0.1% | 31,800 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $1,355,000 | +2.2% | 31,300 | -3.7% | 0.00% | 0.0% |
| Q1 2021 | $1,326,000 | -8.2% | 32,500 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $1,444,000 | +27.9% | 31,900 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,129,000 | -6.2% | 31,900 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,204,000 | +50.3% | 31,900 | +15.2% | 0.00% | 0.0% |
| Q1 2020 | $801,000 | -41.5% | 27,700 | +4.9% | 0.00% | 0.0% |
| Q4 2019 | $1,369,000 | -5.5% | 26,400 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $1,449,000 | +35.2% | 26,400 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $1,072,000 | +39.0% | 26,400 | +3.5% | 0.00% | 0.0% |
| Q1 2019 | $771,000 | -10.0% | 25,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $857,000 | -20.4% | 25,500 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,076,000 | +31.9% | 25,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $816,000 | -35.6% | 25,500 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $1,268,000 | -3.2% | 25,500 | +4.9% | 0.00% | +100.0% |
| Q4 2017 | $1,310,000 | -7.0% | 24,300 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,409,000 | +17.5% | 24,300 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $1,199,000 | +13.5% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,056,000 | -11.3% | 24,300 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $1,190,000 | +10.5% | 24,300 | +8.0% | 0.00% | 0.0% |
| Q3 2016 | $1,077,000 | -17.4% | 22,500 | -7.4% | 0.00% | 0.0% |
| Q2 2016 | $1,304,000 | +29.8% | 24,300 | +4.3% | 0.00% | 0.0% |
| Q1 2016 | $1,005,000 | +39.4% | 23,300 | +23.3% | 0.00% | 0.0% |
| Q4 2015 | $721,000 | +19.8% | 18,900 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $602,000 | +11.1% | 18,900 | +15.2% | 0.00% | +100.0% |
| Q2 2015 | $542,000 | -19.7% | 16,400 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $675,000 | +6.1% | 16,400 | +5.1% | 0.00% | 0.0% |
| Q4 2014 | $636,000 | +11.2% | 15,600 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $572,000 | -20.9% | 15,600 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $723,000 | +19.7% | 15,600 | +6.1% | 0.00% | +50.0% |
| Q1 2014 | $604,000 | +40.1% | 14,700 | +30.1% | 0.00% | 0.0% |
| Q4 2013 | $431,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
| CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
| Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
| DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
| Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
| Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
| Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
| Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |